ConductScience.org, home

Paper36307751

A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma.

Zhang G and 4 others. BMC Cancer, 2022. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma. Papers, record 36307751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36307751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma.
PubMed
Journal
BMC Cancer
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.78
iCite
Revised in PubMed
2022-11-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang GGenhao
2Zhang KKai
3Zhao YYanteng
4Yang QQiankun
5Lv XXianping

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
Humans
Prognosis
Gene Expression Regulation, Neoplastic
Biomarkers, Tumor
Immunotherapy
Hypoxia
Tumor Microenvironment

Source PubMed

Download CSV of topics

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131350295The Tumor Microenvironment Innately Modulates Cancer Progression.Cancer Res2019https://conductscience.org/library/papers/31350295PubMed
226193342The prognostic landscape of genes and infiltrating immune cells across human cancers.Nat Med2015https://conductscience.org/library/papers/26193342PubMed
328187285Transcriptional Addiction in Cancer.Cell2017https://conductscience.org/library/papers/28187285PubMed
428703774Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis.Int J Mol Sci2017https://conductscience.org/library/papers/28703774PubMed
534627241A novel tumor doubling time-related immune gene signature for prognosis prediction in hepatocellular carcinoma.Cancer Cell Int2021https://conductscience.org/library/papers/34627241PubMed
632037619Circ-HOMER1 enhances the inhibition of miR-1322 on CXCL6 to regulate the growth and aggressiveness of hepatocellular carcinoma cells.J Cell Biochem2020https://conductscience.org/library/papers/32037619PubMed
731441380C7 peptide inhibits hepatocellular carcinoma metastasis by targeting the HGF/c-Met signaling pathway.Cancer Biol Ther2019https://conductscience.org/library/papers/31441380PubMed
821965748Effects of acute and chronic hypoxia on the radiosensitivity of gastric and esophageal cancer cells.Anticancer Res2011https://conductscience.org/library/papers/21965748PubMed
929092952TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.Cancer Res2017https://conductscience.org/library/papers/29092952PubMed
1033568167Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.Cancer Cell Int2021https://conductscience.org/library/papers/33568167PubMed
1133824268CAR-T cell therapy: current limitations and potential strategies.Blood Cancer J2021https://conductscience.org/library/papers/33824268PubMed
1220581454Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics.Cancer Biol Ther2010https://conductscience.org/library/papers/20581454PubMed
1329525632CLEC1B Expression and PD-L1 Expression Predict Clinical Outcome in Hepatocellular Carcinoma with Tumor Hemorrhage.Transl Oncol2018https://conductscience.org/library/papers/29525632PubMed
1435964022Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma.BMC Cancer2022https://conductscience.org/library/papers/35964022PubMed
1527124451Hypoxic control of metastasis.Science2016https://conductscience.org/library/papers/27124451PubMed
1635734199CLEC1B is a Promising Prognostic Biomarker and Correlated with Immune Infiltration in Hepatocellular Carcinoma.Int J Gen Med2022https://conductscience.org/library/papers/35734199PubMed
1735432539Prognosis and Characterization of Immune Microenvironment in Head and Neck Squamous Cell Carcinoma through a Pyroptosis-Related Signature.J Oncol2022https://conductscience.org/library/papers/35432539PubMed
1828123387Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma.Front Immunol2016https://conductscience.org/library/papers/28123387PubMed
1922169972HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression.Nat Rev Cancer2011https://conductscience.org/library/papers/22169972PubMed
2035615530Platelet-Related Molecular Subtype to Predict Prognosis in Hepatocellular Carcinoma.J Hepatocell Carcinoma2022https://conductscience.org/library/papers/35615530PubMed

See all 62 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42584769A novel hypoxia-related signature for predicting prognosis, immune characteristics, and therapeutic response in hepatocellular carcinoma.Discov Oncol2026https://conductscience.org/library/papers/42584769PubMed
41050884Angiogenesis and Immunosuppressive Niche in Hepatocellular Carcinoma: Reshaping Vascular - Immune Axis to Potentiate antiPD - 1/PD - L1 Therapy.Cancer Manag Res2025https://conductscience.org/library/papers/41050884PubMed
41050691Stemness- and hypoxia-based prognostic stratification index reveals G6PD as a regulator of hypoxia-driven stemness in hepatocellular carcinoma.Front Immunol2025https://conductscience.org/library/papers/41050691PubMed
39961903Molecular subtyping combined with multiomics analysis to study correlation between TACE refractoriness and tumor stemness in hepatocellular carcinoma.Discov Oncol2025https://conductscience.org/library/papers/39961903PubMed
39807391Investigating combined hypoxia and stemness indices for prognostic transcripts in gastric cancer: Machine learning and network analysis approaches.Biochem Biophys Rep2025https://conductscience.org/library/papers/39807391PubMed
38870259Prognostic implication and immunotherapy response prediction of a novel ubiquitination-related gene signature in liver cancer.Aging (Albany NY)2024https://conductscience.org/library/papers/38870259PubMed
38751862Construction of a Prognostic Model for Hepatocellular Carcinoma Based on Macrophage Polarization-Related Genes.J Hepatocell Carcinoma2024https://conductscience.org/library/papers/38751862PubMed
37370848Identification, and Experimental and Bioinformatics Validation of an Immune-Related Prognosis Gene Signature for Low-Grade Glioma Based on mRNAsi.Cancers (Basel)2023https://conductscience.org/library/papers/37370848PubMed
37034207The role of the stemness index-associated signature in the analysis of the tumorigenesis of liver cancer patients of different races.Am J Cancer Res2023https://conductscience.org/library/papers/37034207PubMed

Download CSV of cited by

Genes35

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACKR511318PubTator's text mininghttps://conductscience.org/library/genes/11318NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD27680381PubTator's text mininghttps://conductscience.org/library/genes/80381NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD44960PubTator's text mininghttps://conductscience.org/library/genes/960NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CHST410164PubTator's text mininghttps://conductscience.org/library/genes/10164NCBI Gene
CLEC1B51266PubTator's text mininghttps://conductscience.org/library/genes/51266NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
CXCL66372PubTator's text mininghttps://conductscience.org/library/genes/6372NCBI Gene
CXCR47852PubTator's text mininghttps://conductscience.org/library/genes/7852NCBI Gene
GLP2R9340PubTator's text mininghttps://conductscience.org/library/genes/9340NCBI Gene
GPC32719PubTator's text mininghttps://conductscience.org/library/genes/2719NCBI Gene
HGF3082PubTator's text mininghttps://conductscience.org/library/genes/3082NCBI Gene
HIF1A3091PubTator's text mininghttps://conductscience.org/library/genes/3091NCBI Gene
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
IL1A3552PubTator's text mininghttps://conductscience.org/library/genes/3552NCBI Gene
IL33R9173PubTator's text mininghttps://conductscience.org/library/genes/9173NCBI Gene

See all 35 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36307751

GET https://conductscience.org/api/papers/v1/36307751/references?page=2